PAIYY · Aesthetic Medical International Holdings Group Ltd · Financials

$0.01 At close · Oct 14

Market Cap

$545,300

48.69M

Volume · Oct 14 230 Avg daily vol (7 sessions) 1833

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

722.86M -4.3%

FY2025

Net Income

-53.35M -167.5%

FY2025

Gross Margin

46.24% +1.5pp

FY2025

Diluted EPS

-0.40 -185.7%

FY2025

Operating Cash Flow

-12.23M -115.3%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue CNY	+2.6%	-4.3%	—	722.86M	755.67M	682.59M	670.09M	645.59M	901.57M	869.05M	761.31M	697.4M
Cost of Revenue CNY	+7.3%	+1.7%	—	388.61M	417.89M	360.54M	314.51M	376.09M	356.8M	275.95M	258.57M	234.52M
Gross Profit CNY	-2.0%	-9.3%	—	334.25M	337.79M	322.05M	355.59M	269.5M	544.78M	593.1M	502.74M	462.87M
General & Administrative CNY	-12.0%	-14.9%	—	102.65M	100.79M	138.61M	150.38M	206.97M	230.65M	196.33M	115.49M	92.84M
Depreciation & Amortization CNY	-1.4%	-11.2%	—	58.89M	65.96M	65.9M	61.49M	99.14M	106.41M	83.83M	32.14M	29.11M
Interest Expense CNY	-26.1%	-21.4%	—	8.75M	8.72M	14.47M	21.64M	27.23M	29.19M	24.29M	9.24M	6.58M
Pretax Income CNY	—	—	—	-24.72M	-1.35M	-55.06M	-94.17M	-681.31M	-259.49M	152.36M	-233.97M	-53.17M
Income Tax CNY	—	—	—	29.35M	23.73M	-15.14M	-18.07M	-11.8M	-12.59M	14.04M	18.51M	19.26M
Net Income CNY	—	—	—	-53.35M	-19.95M	-37.43M	-76.25M	-586.62M	-235.48M	136.31M	-255.24M	-76.68M

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: 6.03M in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Borrowings	2025-12-31	CNY 144,252,000	20-F filed 2026-04-23
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current borrowings, including current portion of noncurrent borrowings CNY 129,081,000 Noncurrent long-term borrowings CNY 15,171,000
Current secured bank loans received, including current portion of noncurrent secured bank loans	2025-12-31	CNY 94,398,000	20-F filed 2026-04-23
Lease liabilities	2025-12-31	CNY 136,333,000	20-F filed 2026-04-23
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current lease liabilities CNY 25,933,000 Noncurrent lease liabilities CNY 110,400,000
Other current borrowings	2025-12-31	CNY 34,683,000	20-F filed 2026-04-23
Other noncurrent borrowings	2025-12-31	CNY 15,171,000	20-F filed 2026-04-23

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1757143 Visit website Investor relations